Not Yet Recruiting The Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI) Combination on Overall Survival in Adults With Advanced Kidney Cancer: A Pragmatic Multicenter, Randomized Controlled Trial. NCT07338981 Conditions Advanced Kidney Cancer Locations BC Cancer - Vancouver Cancer Centre — Vancouver, British Columbia, Canada View Trial Details
Completed Circulating and Urinary Exosomal miRNA in Advanced Kidney Cancer (EXO-RENAL1) NCT07406646 Conditions Adenocarcinoma, Advanced Kidney Cancer, Carcinoma, +15 more Locations Institute of Oncology Ljubljana — Ljubljana, Slovenia View Trial Details
Active, Not Recruiting Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer NCT03308396 Conditions Adenocarcinoma, Advanced Kidney Cancer, Carcinoma, +16 more Locations Univerisity of Illinois Cancer Center — Chicago, Illinois, United States University of Iowa Hosptials and Clinics — Iowa City, Iowa, United States University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey, United States View more locations Show fewer locations Loading locations... View Trial Details
